Abstract
Abtract: Objective This randomized controlled study examines the effect of repetitive transcranial magnetic stimulation on contralesional dorsal premotor cortex in patients in the subaucte phase of stroke recovery. Methods This randomized controlled study includes three groups: contralesional dorsal premotor cortex(cPMd), contralesional primary motor cortex(cM1) and sham stimulation. 60 Participants were divided into 3 groups according to random block method. They all received a 3-week intervention. The primary outcome was using the Fugl Meyer Assessment (FMA) to evaluate the motor function of the affected limb. The secondary outcomes included: Brunnstrom hemiplegia grading, Action Research Arm Test (ARAT), Wolf Motor Function Test (WMFT), Barthel Index (BI), electrophysiological assessment (bilateral hemisphere MEP, ipsilesional central conduction time, ipsilesional latency). Results Comparative analysis revealed that the cPMd group demonstrated significant improvements in both the Fugl-Meyer Assessment for Upper Extremity (FMA-UE) and distal upper limb scores relative to the cM1 group (P<0.05) and the sham group (P<0.001). What s more, the cPMd group exhibited marked enhancementsin FMA for Lower Extremity (FMA-LE), proximal upper limb, and hand scores (P≤0.01) compared to the sham stimulation group. However, the study revealed limited improvements in electrophysiological assessments, with only ipsilesional central conduction time showing significant changes compared to the sham group. Discussion This study provides some evidence for the effect of high-frequency rTMS stimulation in the cPMd on improving stroke motor disorders. The cPMd group showed significant improvement in FMA-UE scores compared to the cM1 group. It suggests that high-frequency rTMS in the cPMd may be a unique and more effective strategy for optimizing brain motor networks and improving patient dysfunction. This provides new ideas for TMS assessment and intervention of brain areas based on complex brain networks and proposes new possible treatment strategies. In the future, a multi-center, large-scale systematic study is needed to explore the use of high-frequency rTMS in the cPMd for stroke hemiplegia recovery, and to further investigate the pathophysiological mechanisms of disease recovery, as well as to explore the neural plasticity mechanism of stroke motor dysfunction recovery. Therefore, the rehabilitation potential of high-frequency rTMS in the cPMd still needs further exploration and better promotion of motor function recovery in stroke patients.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ChiCTR1900027399
Funding Statement
This study was funded by the General Program of the National Natural Science Foundation of China (81974356), the General Program of the Shanghai Natural Science Foundation (23ZR1408500),Key Supporting Discipline Construction Project of Shanghai Health System (2023ZDFC0304),National Natural Science Foundation of China (82102665),Shanghai Sailing Program(21YF1404600),Key Discipline Program of Shanghai Municipal Health System (2024ZDXK0032),Shanghai Jing'an District Key Clinical Specialty Program for Traditional Chinese Medicine Rehabilitation (JA2024-Z005)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Huashan Hospital. Fudan University gave ethical approval for this work(EC Approval No.2019-504).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors